Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the percentage reduction in febrile reactions (rectal temperature >=38.0°C or oral/axillary/tympanic >=37.5°C) when prophylactic antipyretic treatment is administered compared to no prophylactic antipyretic treatment, after booster vaccination with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine and routine DTPa-HBV-IPV/Hib (Infanrix hexa) vaccination in children at 12-15 months of age.
Critère d'inclusion
- A single dose booster vaccination against Streptococcus pneumoniae of healthy children between 12-15 months of age who were previously primed with three doses of GSK Biologicals’10-valent conjugate pneumococcal vaccine in the primary vaccination study 10PN-PD-DIT-010 and a first single dose vaccination against meningococcal disease due to serogroups A, C, W-135, or Y, of pneumococcal vaccine unprimed healthy children of 12-15 months of age